$0.45
+0.07 (+16.93%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+621.6% upside
Low Target
$1.82
Average Target
$3.24
High Target
$4.40
Current Price
$0.45
Current
$0.45
$0.45
Target
$3.24
$3.24
$1.82
$3.24 avg
$4.40
Scenario Analysis
Bear Case
$1.82
305.3%
Low target
Base Case
$3.24
+621.6%
Avg target
Bull Case
$4.40
+880.0%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$2.88
-84.4% from high
52-Week Low
$0.34
+31.9% from low
Target vs 52W High
$3.24
+12.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |